| LTR | NCR | ENV | ETR |
---|---|---|---|---|
# primer combinations | 2 | 3 | 1 | 3 |
% of patients expected to generate amplicons based on in silico analysis* | 59.25 | 80.37 | 89.42 | 60.33 |
% of patients in which DNA was amplified | 51.40 | 81.94 | 100 | 63.90 |
% of patients for which the DNA had sufficient quality to be mapped to HIV-1 | 48.61 | 75.00 | 41.67 | 63.90 |